Biostar Pharmaceuticals, a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, announced its variable interest entity in China, Shaanxi Aoxing Pharmaceutical, has renewed its Good Manufacturing Practices (GMP) certificate and Pharmaceutical Production License. The company received the renewed GMP certificate evidencing compliance on January 31, 2018.
"The Company is pleased to have completed the GMP certification inspection and approval process. We expect that the GMP certification renewal will allow us to resume our production in the coming months as the company makes preparations to carry on with the implementation of its business plan and growth objectives," Wang Ronghua, Chairman of Biostar, said.